Annual report pursuant to Section 13 and 15(d)

Schedule II - Valuation and Qualifying Accounts

v3.20.4
Schedule II - Valuation and Qualifying Accounts
12 Months Ended
Jan. 02, 2021
Notes to Financial Statements  
SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]

USANA HEALTH SCIENCES, INC. AND SUBSIDIARIES

SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS

(in thousands)

 

Description

 

Balance at beginning of period

   

Charged to costs and expenses

   

Deductions

   

Balance at end of period

 
                                 

January 2, 2021

                               

Allowance for sales returns

  $ 772     $ 115     $ 68     $ 819  

Allowance for doubtful accounts

  $ 261     $ 131     $ 20     $ 372  

Valuation allowance - deferred tax assets

  $ 64,285     $ 17,116     $ -     $ 81,401  
                                 

December 28, 2019

                               

Allowance for sales returns

  $ 839     $ 168     $ 235     $ 772  

Allowance for doubtful accounts

  $ 139     $ 146     $ 24     $ 261  

Valuation allowance - deferred tax assets

  $ 44,199     $ 20,086     $ -     $ 64,285  
                                 

December 29, 2018

                               

Allowance for sales returns

  $ 632     $ 307     $ 100     $ 839  

Allowance for doubtful accounts

  $ 325     $ 8     $ 194     $ 139  

Valuation allowance - deferred tax assets

  $ 13,980     $ 30,219     $ -     $ 44,199